Current and Emerging Issues in Wilsons Disease
NEJM 389:922-938, Roberts,E.A. & Schilsky, M.L., 2023
Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Medicine 86:112-121, Taly,A.B., et al, 2007
Diagnosis and Treatment of Wilson's Disease
Semin Neurol 19:261-270, Brewer,G.J.,et al, 1999
Development of Neurologic Symptoms in a Patient with Asymptomatic Wilson's Disease Treated with Penicillamine
Arch Neurol 51:304-305, Brewer,G.J.,et al, 1994
Wilson Disease
Medicine 71:139-164, Brewer,G.J.&Yuzbasiyan-Gurkan,V., 1992
Wilson's Disease:Current Status
Am J Med 92:643-654, Yarze,J.C.,et al, 1992
Wilson Disease:Clinical Presentation, Treatment, and Survival
Ann Int Med 115:720-726, Stremmel,W.,et al, 1991
Wilson's Disease, Development of Neurological Disease after Beginning Penicillamine Therapy
Arch Neurol 47:595-596, Glass,J.D.,et al, 1990
Diagnosis and Treatment of Presymptomatic Wilson's Disease
Lancet 2:435-437, Walshe,J.M., 1988
Liver Transplantation as a Rescue Therapy for Severe Neurologic Forms of Wilson Disease
Neurol 94:e2189-e2202, Poujois, A.,et al, 2020
Muscle Stiffness, Gait Instability, and Liver Cirrhosis in Wilsons Disease
Lancet 396:990, Kronlage, C.,et al, 2020
Wilson Disease
Yamada Textbook of Gastroenterology Chp 102, Metabolic Diseases of Liver, 6th Ed, Sunderam, S.S., & Sokol, R.J., 2016
Inherited Metabolic Diseases of the Nervous System, Hepatolenticular Degeneration (Wilson Disease)
Adams & Victors Principles of Neurology, Chp 37, pg 982, Ropper, A.H.,et al, 2014
Teaching NeuroImages: MRI Reversal in Wilson Disease With Trientine Treatment
Neurol 74:e72, Park,H.K., et al, 2010
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Effect of Liver Transplantation on Neurological Manifestations in Wilson Disease
ArchNeurol 57:384-386, Stracciari,A.,et al, 2000
Cerebral Manifestation of Wilson's Disease Successfully Treated with Liver Transplantation
Neurol 51:863-865, Bax,R.T.,et al, 1998
Treatment of Wilson Disease with Ammonium Tetrathiomolybdate
Arch Neurol 53:1017-1025, Brewer,G.J.,et al, 1996
Zinc-Induced Deterior in Wilson's Disease Aborted by Trtm with Penicillamine, Dimercaprol, & A Novel Zero Copper Diet
Arch Neurol 52:10-11, Walshe,J.M.,et al, 1995
Treatment of Wilson's Disease with Ammonium Tetrathiomolybdate
Arch Neurol 51:545-554, Brewer,G.J.,et al, 1994
Initial and Follow-up Brain MRI Findings and Correlation with the Clinical Course in Wilson's Disease
Neurol 44:1064-1068, Roh,J.K.,et al, 1994
Worsening of Neurologic Syndrome in Patients with Wilson's Disease with Initial Penicillamine Therapy
Arch Neurol 44:490-493, Brewer,G.J.,et al, 1994
Disappearance of Kayser-Fleischer Rings Following Liver Transplantation
Transplant Proc 24:1483-1485, Song,H.S.,et al, 1992
The Dystonias
BMJ 300:139-144, Marsden,C.D.&Quinn,N.P., 1990
Evoked Potentials in Assessment and Follow-up of Patients with Wilson's Disease
Lancet 336:963-964, Grimm,G.,et al, 1990
The Use of Trientine in Preventing the Effects of Interrupting Penicillamine Therapy in Wilson's Disease
NEJM 317:209-213, Scheinberg,I.H.,et al, 1987
Wilson's Disease
BMJ 288:1180-1181, Parkes,D., 1984
Effective Treatment of Wilson's Disease with Oral Zinc Sulphate:Two Case Reports
BMJ 289:273-276, Hoogenraad,T.U.,et al, 1984
Oral Zinc Therapy for Wilson's Disease
Ann Int Med 99:314-320, Brewer,G.J.,et al, 1983
Treatment of Wilson's Disease
Ann Int Med 99:398-400, Cummings,J.N.,et al, 1983
Treatment Of Wilson's Disease With Trientine (Triethylene Tetramine) Dihydrochloride
Lancet 1:643-647, Walshe,J.M., 1982
Diagnosis of Treatable Wilson's Disease
NEJM 298:1347, Cartwright,G.E., 1978
Medical Management and Revascularization for Asymptomatic Carotid Stenosis
NEJM 394:219-231 296, Hrott,T.G.,et al, 2026
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025
Risdiplam in Presymptomatic Spinal Muscular Atrophy
NEJM 393:671-682, Finkel,R.S.,et al, 2025
Neurosyphilis
Ann Neurol 98:1070-1076, Minter,D.J. & Chow,F.C., 2025
Granulomatosis with Polyangiitis Presenting as Isolated Ear Involvement A Case Series and Literature Review
ACTA Otorhinolaryngol Italica 45:217-230, Zorzi,S.,et al, 2025
Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
NEJM 391:1256-1258, Laugwitz,L.,et al, 2024
Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease
Stroke 55:2632-2640, Poorthuis,M.H.F.,et al, 2024
A 65-Year-Old Woman with Isolated Macroglossia as the Initial Presentation of a Rare Disease
Neurol 103:e210070, Lara,C.,et al, 2024
Spontaneous Calcified Cerebral Emboli:A Comprehensive Review and Proposed Diagnostic Criteria
Front Neurol doi:10.3389/fneur.2024.1401820, Menounos,S., & Mater,W., 2024
A 60-Year Old Man with Asymmetric Weakness and Persistent Fever
Neurol 100:530-536, Zheng,Y.,et al, 2023
Primary Brain Tumours in Adults
Lancet 402:1564-1579, van den Bent,M.,et al, 2023
Pachymeningitis and Aortitis as the Initial Presentation of Granulomatosis with Polyangiitis
Neurol 101:979-980, Li,X.,et al, 2023
Hereditary Hemorrhagic Telangiectasia, Clinical Presentations, and Management
Stroke 54:e512-e515, Silveira,L.,et al, 2023
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis
Ann Neurol 92:201-212, Lindgren, U.,et al, 2022
HIV Infection - Screening, Diagnosis, and Treatment
NEJM 384:2131-2143, Saag, M.S., 2021